Vaccine Hopes & Upbeat Data Lift Stocks

Vaccine optimism boosted risk appetite, lifting Asian markets overnight putting European bourses on track for a stronger start. Upbeat UK inflation data has added to the risk on tone

Charts (3)

Vaccine optimism boosted risk appetite, lifting Asian markets overnight putting European bourses on track for a stronger start. Stronger than forecast UK inflation data has added to the risk on tone. Meanwhile, elevated US – Chinese tensions are broadly being shrugged off.

Risk sentiment has soared after Moderna Inc said that its covid-19 vaccine candidate produced a “robust” immune response in all 45 patients in its early stage trial and without safety issues. The findings support further development of the vaccine and Phase 3 trials are expected to start at the end of this month. 

A vaccine is the surest and quickest way for the global economy to bounce back to pre-coronavirus levels. Social distancing would no longer be needed, shops and particularly the leisure and hospitality sectors could return to business as usual. In shot a vaccine is the only way to recession proof the economy against coronavirus. For this reason, the markets are so sensitive towards vaccine development news. As we move through the second half of the year, we can expect vaccine news to pick up, with Oxford University /AstraZeneca already in Phase 3 testing in south Africa and Brazil. 

UK Inflation surges
UK inflation surged +0.6% mom in June unexpectedly picking up from May and surpassing expectation s of 0.4%. On an annual basis, inflation increased 1.4%, ahead of the 1.2% forecast. As lockdown measures were eased and the UK economy gradually reopened, demand has picked up boosting inflation. This is some well needed good news after yesterday’s GDP misery and has returned some faith that he UK economy is on the road to recovery, albeit a long road. 

Petrol prices played a part as oil continues to climb from its March nadir and as Brits jump back into their cars after lock. Core inflation was slightly less impressive, slipping to a still solid 0.5%. GBP/USD trades +0.3%.

China troubles brushed off
As risk appetite rises stocks are pushing higher and the safe haven dollar has fallen out of favour. News that President Trump has ordered an end to Hong Kong’s special status in relation against China’s national security law in Hong Kong has broadly gone unnoticed. This follows reports that the UK will phase out the use of Huawei technology.
Coronavirus numbers are also being overshadowed by vaccine optimism. The tally in the US reached 3.4 million, with 136,000 deaths recorded. California has re-imposed lockdown measures across the hardest hit counties in the state amid record covid numbers.

EUR solid on stimulus hopes
On the currency markets, the Euro is a star performer rising to 4 month highs on hopes that the economic recovery stimulus plan will be agreed after Germany’s Angela Merkel and Spain’s PM Pedro Sanchez committed to moving forward with the EU Fund.

FTSE Chart


More from FTSE 100

From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.